Use of PDGF receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy

Details for Australian Patent Application No. 2005244525 (hide)

Owner Southern Health Atkins, R. Chadban, S. Cooper, M. Gilbert, R. Hill, P. Kelly, D. Nikolic-Paterson, D. The University of Melbourne

Inventors Hill, Prudence Ann; Nikolic-Paterson, David John; Chadban, Steven James; Cooper, Mark Emmanuel; Gilbert, Richard Ernest; Kelly, Darren James; Atkins, Robert Charles

Agent Davies Collison Cave

Pub. Number AU-A-2005244525

Parent 2001248324

Filing date 14 December 2005

Wipo publication date 12 January 2006

International Classifications

A61K 31/00 (2006.01)

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

Event Publications

5 January 2006 Complete Application Filed

12 January 2006 Application Open to Public Inspection

  Published as AU-A-2005244525

13 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005244526-Immunoregulatory Compounds and Derivatives and methods of treating diseases therewith

2005244524-Devices and methods for biochip multiplexing